Efficacy and safety of newly developed ganirelix acetate in infertile women for assisted reproductive technology: a prospective, randomised, controlled study
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
- Publicado em
- 7 mar 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of newly developed ganirelix acetate in infertile women for assisted reproductive technology: a prospective, randomised, controlled study
E Jung Han, Sang Woo Lyu, In Pyung Kwak, Hwang Kwon, Dong Hee Choi, Jin Young Kim, Han Moie Park, Ji-Won Kim, Eun Mi Chang, Hee Jun Lee et al.
Descritores MeSH
- Infertility, Female
- Fertilization in Vitro
- Chorionic Gonadotropin
- Hormone Antagonists
- Humans
- Luteinizing Hormone
- Gonadotropin-Releasing Hormone
- Ovulation Induction
- Female
- Prospective Studies
Veja também
Estudos relacionados
- Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study
- Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
- Recombinant-luteinzing hormone supplementation in women during IVF/ICSI cycles with GNRH-antagonist protocol: A systematic review and meta-analysis
- Nonlinear association of serum luteinizing hormone on hCG trigger day with cumulative live birth in IVF cycles: secondary analysis of a randomized clinical trial